Cost model for biobanks.
Current economic conditions and budget constraints in publicly funded biomedical research have brought about a renewed interest in analyzing the cost and economic viability of research infrastructures. However, there are no proposals for specific cost accounting models for these types of organizations in the international scientific literature. The aim of this paper is to present the basis of a cost analysis model useful for any biobank regardless of the human biological samples that it stores for biomedical research. The development of a unique cost model for biobanks can be a complicated task due to the diversity of the biological samples they store. Different types of samples (DNA, tumor tissues, blood, serum, etc.) require different production processes. Nonetheless, the common basic steps of the production process can be identified. Thus, the costs incurred in each step can be analyzed in detail to provide cost information. Six stages and four cost objects were obtained by taking the production processes of biobanks belonging to the Spanish National Biobank Network as a starting point. Templates and examples are provided to help managers to identify and classify the costs involved in their own biobanks to implement the model. The application of this methodology will provide accurate information on cost objects, along with useful information to give an economic value to the stored samples, to analyze the efficiency of the production process and to evaluate the viability of some sample collections.
1 Faculty of Business Administration and Tourism; University of Vigo, Campus of Ourense , Spain .
M Beatriz
MB
Gonzalez-Sanchez
Ernesto
E
Lopez-Valeiras
Manuel M
MM
Morente
Orlando
O
Fernández Lago
D018070:Biological Specimen Banks / Q000191:economics* / Q000458:organization & administration; D002017:Budgets; D003365:Costs and Cost Analysis / Q000379:methods*; D006801:Humans; D018803:Models, Economic